BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $226,000 | +4.1% | 2,631 | -2.8% | 0.01% | 0.0% |
| Q3 2021 | $217,000 | -5.2% | 2,706 | -4.8% | 0.01% | -11.1% |
| Q2 2021 | $229,000 | -5.8% | 2,841 | -1.7% | 0.01% | -10.0% |
| Q1 2021 | $243,000 | -11.3% | 2,891 | -15.5% | 0.01% | -16.7% |
| Q4 2020 | $274,000 | -3.9% | 3,421 | -3.7% | 0.01% | -7.7% |
| Q3 2020 | $285,000 | -37.1% | 3,551 | -32.5% | 0.01% | -40.9% |
| Q2 2020 | $453,000 | -6.8% | 5,261 | -12.2% | 0.02% | -24.1% |
| Q1 2020 | $486,000 | -1.2% | 5,995 | +1.7% | 0.03% | +16.0% |
| Q4 2019 | $492,000 | -4.3% | 5,892 | +0.4% | 0.02% | -10.7% |
| Q3 2019 | $514,000 | +5.1% | 5,871 | -1.7% | 0.03% | +7.7% |
| Q2 2019 | $489,000 | -17.4% | 5,970 | -18.1% | 0.03% | -18.8% |
| Q1 2019 | $592,000 | -17.3% | 7,290 | -33.0% | 0.03% | -25.6% |
| Q4 2018 | $716,000 | -11.6% | 10,886 | +3.6% | 0.04% | 0.0% |
| Q3 2018 | $810,000 | +4.4% | 10,505 | -0.1% | 0.04% | 0.0% |
| Q2 2018 | $776,000 | +14.5% | 10,511 | +0.9% | 0.04% | +10.3% |
| Q1 2018 | $678,000 | -11.4% | 10,416 | -11.9% | 0.04% | -7.1% |
| Q4 2017 | $765,000 | +6.2% | 11,828 | +3.1% | 0.04% | +2.4% |
| Q3 2017 | $720,000 | -0.3% | 11,468 | -3.8% | 0.04% | -4.7% |
| Q2 2017 | $722,000 | +5.6% | 11,918 | -9.7% | 0.04% | +4.9% |
| Q1 2017 | $684,000 | -75.9% | 13,193 | -79.4% | 0.04% | -77.0% |
| Q4 2016 | $2,840,000 | -12.0% | 64,059 | -5.5% | 0.18% | -12.3% |
| Q3 2016 | $3,228,000 | +0.8% | 67,804 | -4.3% | 0.20% | 0.0% |
| Q2 2016 | $3,202,000 | +9.5% | 70,827 | -0.5% | 0.20% | +8.0% |
| Q1 2016 | $2,924,000 | +5.3% | 71,192 | -2.2% | 0.19% | +8.0% |
| Q4 2015 | $2,776,000 | +15.0% | 72,760 | -0.9% | 0.17% | +13.0% |
| Q3 2015 | $2,413,000 | -53.4% | 73,448 | -0.8% | 0.15% | -48.8% |
| Q2 2015 | $5,179,000 | -0.3% | 74,068 | -2.3% | 0.30% | +2.0% |
| Q1 2015 | $5,193,000 | -6.3% | 75,809 | +0.3% | 0.30% | -5.1% |
| Q4 2014 | $5,542,000 | +1.0% | 75,617 | -1.1% | 0.31% | 0.0% |
| Q3 2014 | $5,489,000 | -1.9% | 76,474 | -1.2% | 0.31% | +0.6% |
| Q2 2014 | $5,597,000 | -2.9% | 77,405 | -1.2% | 0.31% | -4.3% |
| Q1 2014 | $5,765,000 | +2.4% | 78,359 | -3.2% | 0.32% | +1.9% |
| Q4 2013 | $5,631,000 | +3.0% | 80,969 | -2.8% | 0.32% | -5.9% |
| Q3 2013 | $5,469,000 | -3.0% | 83,263 | +2.3% | 0.34% | -7.7% |
| Q2 2013 | $5,639,000 | -4.2% | 81,404 | +0.4% | 0.36% | -3.9% |
| Q1 2013 | $5,889,000 | – | 81,070 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |